Article
Modified Recombinant Allergens for Safer Immunotherapy
1 Jan 2006
Abstract excerpt
Molecular cloning and recombinant production of allergens offered new perspectives for the increasing problem of allergies. A variety of preparations are being developed aiming to increase safety and improve efficacy of specific immunotherapy. Recombinant-based approaches are mostly focused on genetic modification of allergens to produce molecules with reduced allergenic activity and conserved antigenicity, i.e....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
